tradingkey.logo
tradingkey.logo
Search

Liminatus Pharma Ord Shs Class A

LIMN
Add to Watchlist
0.104USD
+0.002+1.76%
Close 07-31 16:00ETQuotes delayed by 15 min
4.66MMarket Cap
LossP/E TTM

LIMN Financials

See Liminatus Pharma Ord Shs Class A's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Liminatus Pharma Ord Shs Class A Earnings Date

Latest Release
May 15, 2026
EPS / Forecast
-0.03/--
Revenue / Forecast
--/--
Period
FY2025 Earnings
Revenue(YoY)
--
--
EPS(YoY)
-0.43
-215.22%
Analyst Rating
--
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
FY2021Q1
Financial Indicators
EPS
---0.03
---0.48
---0.07
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Net Profit
---1.12M
-840.78%-8.17M
-183.61%-1.82M
-78.45%-868.31K
-98.49%-642.90K
-329.57%-534.85K
-32.30%-858.23K
-4474.55%-486.60K
-111.86%-323.89K
-93.72%232.98K
-117.00%-648.72K
96.03%-10.64K
-59.61%2.73M
2405.10%3.71M
294.34%3.82M
---267.84K
--6.76M
---161.06K
---1.96M
Debt to assets ratio
--51.70%
--281.30%
--107.46%
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Operating profit
---1.10M
-69.13%-884.21K
31.24%-701.17K
17.60%-522.79K
-50.77%-1.02M
-70.90%-642.08K
-17.07%-721.75K
51.83%-634.43K
-310.49%-676.32K
-28.67%-375.70K
-5.45%-616.49K
8.88%-1.32M
208.72%321.30K
26.12%-291.99K
-46.88%-584.63K
---1.45M
---295.52K
---395.23K
---398.02K
Net Profit
---1.12M
-840.78%-8.17M
-183.61%-1.82M
-78.45%-868.31K
-98.49%-642.90K
-329.57%-534.85K
-32.30%-858.23K
-4474.55%-486.60K
-111.86%-323.89K
-93.72%232.98K
-117.00%-648.72K
96.03%-10.64K
-59.61%2.73M
2405.10%3.71M
294.34%3.82M
---267.84K
--6.76M
---161.06K
---1.96M
Current assets
--2.78M
-38.40%500.57K
205.28%1.20M
285.36%812.66K
10.58%394.19K
123.46%409.16K
661.20%1.51M
-41.53%210.88K
5.23%356.48K
-52.64%183.10K
-37.83%198.05K
-14.52%360.65K
-56.66%338.76K
-61.90%386.60K
-77.87%318.55K
--421.92K
--781.65K
--1.01M
--1.44M
Total current liabilities
--2.89M
18.62%10.30M
-61.99%2.86M
68.29%8.68M
63.67%7.54M
60.81%6.47M
89.31%6.95M
43.64%5.16M
168.51%4.60M
93.23%4.02M
97.09%3.67M
160.17%3.59M
482.03%1.71M
796.88%2.08M
611.32%1.86M
--1.38M
--294.62K
--232.10K
--261.72K
Total assets
--2.79M
-81.87%512.79K
-56.25%1.34M
-37.17%2.83M
-32.69%3.07M
-75.97%3.54M
-68.58%4.63M
-70.93%4.50M
-98.36%4.56M
-94.67%14.72M
-94.67%14.72M
-94.40%15.49M
0.24%277.45M
-0.29%276.20M
-0.40%276.34M
--276.44M
--276.79M
--277.02M
--277.44M
Total liabilities
--2.92M
-44.77%10.33M
-82.75%2.99M
23.06%18.70M
17.33%17.32M
17.46%16.61M
19.33%17.16M
7.05%15.19M
21.23%14.76M
3.44%14.14M
-18.55%14.38M
-34.20%14.19M
-43.76%12.18M
-52.29%13.67M
-38.91%17.66M
--21.57M
--21.65M
--28.64M
--28.90M
Total equity
---132.60K
38.16%-9.81M
88.45%-1.65M
-48.42%-15.87M
-39.67%-14.25M
-2353.20%-13.07M
-3781.45%-12.53M
-926.20%-10.69M
-103.85%-10.21M
-99.78%580.04K
-99.87%340.48K
-99.49%1.29M
3.97%265.27M
5.70%262.54M
4.08%258.68M
--254.87M
--255.14M
--248.37M
--248.54M
Net operating income
---2.02M
50.75%-386.85K
17.65%-600.61K
-25.26%-785.50K
-35.23%-729.36K
-252.47%-687.89K
-24.21%-903.72K
-1153.58%-627.10K
-17.31%-539.35K
62.63%-195.16K
-1044.76%-727.57K
79.30%-50.02K
-299.42%-459.76K
-70.24%-522.24K
88.49%-63.56K
---241.64K
---115.11K
---306.77K
---552.36K
Net investment
--0.00
100.00%0.00
-102.70%-13.11K
-34.31%-57.34K
-95.48%485.53K
19729.45%1.29M
-63.86%248.83K
-100.02%-42.70K
--10.75M
---6.58K
--688.55K
--263.96M
--0.00
--0.00
100.00%0.00
--0.00
--0.00
--0.00
---276.00M
Net financing
--3.59M
-100.00%0.00
-100.00%0.00
12.59%550.00K
102.63%262.80K
-271.47%-465.67K
456.62%700.00K
100.19%488.50K
-1949.77%-9.99M
-9.47%271.58K
---196.29K
---263.76M
--540.00K
--300.00K
-100.00%0.00
--0.00
--0.00
--0.00
--277.55M

FAQs

What are the current assets of Liminatus Pharma Ord Shs Class A?

According to Liminatus Pharma Ord Shs Class A's FY2025 earnings report, its current assets were 500.57K, with a year-on-year change of -90.52.

What are the total assets of Liminatus Pharma Ord Shs Class A?

According to Liminatus Pharma Ord Shs Class A's FY2025 earnings report, its total assets of Liminatus Pharma Ord Shs Class A were 512.79K, with a year-on-year change of -90.52.

What are the total liabilities of Liminatus Pharma Ord Shs Class A?

According to Liminatus Pharma Ord Shs Class A's FY2025 earnings report, its total liabilities of Liminatus Pharma Ord Shs Class A were 10.33M, with a year-on-year change of -58.27.

What is the total equity of Liminatus Pharma Ord Shs Class A?

According to Liminatus Pharma Ord Shs Class A's FY2025 earnings report, its total equity of Liminatus Pharma Ord Shs Class A was -9.81M, with a year-on-year change of 49.25.

What is the net operating income of Liminatus Pharma Ord Shs Class A?

According to Liminatus Pharma Ord Shs Class A's FY2025 earnings report, its net operating income of Liminatus Pharma Ord Shs Class A was -2.97M, with a year-on-year change of 10.88.

What is the net investment of Liminatus Pharma Ord Shs Class A?

According to Liminatus Pharma Ord Shs Class A's FY2025 earnings report, its net investment of Liminatus Pharma Ord Shs Class A was -788.11K, with a year-on-year change of 72.35.

What is the net financing of Liminatus Pharma Ord Shs Class A?

According to Liminatus Pharma Ord Shs Class A's FY2025 earnings report, its net financing of Liminatus Pharma Ord Shs Class A was 11.03M, with a year-on-year change of 181.23.

What is the Earnings Per Share (EPS) of Liminatus Pharma Ord Shs Class A?

According to Liminatus Pharma Ord Shs Class A's FY2025 earnings report, its Earnings Per Share (EPS) was -0.43, with a year-on-year change of -215.22.

What is the net income of Liminatus Pharma Ord Shs Class A?

According to Liminatus Pharma Ord Shs Class A's FY2025 earnings report, its net income was -10.21M, with a year-on-year change of -187.83.

What is the debt-to-asset ratio of Liminatus Pharma Ord Shs Class A?

According to Liminatus Pharma Ord Shs Class A's FY2025 earnings report, its debt-to-asset ratio was 281.30, with a year-on-year change of -23.82.

What is the Return on Assets (ROA) of Liminatus Pharma Ord Shs Class A?

According to Liminatus Pharma Ord Shs Class A's FY2025 earnings report, its Return on Assets (ROA) was -344.71, with a year-on-year change of -271.88.

What is the operating profit of Liminatus Pharma Ord Shs Class A?

According to Liminatus Pharma Ord Shs Class A's FY2025 earnings report, its operating profit was -2.97M, with a year-on-year change of 10.88.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.